BEETA 25 mg

Composition:

• Active Ingredient:

  • Metoprolol Succinate (Extended-Release): 25 mg

Formulation:

• Form: Extended-release tablet

• Dosage Strength: 25 mg of Metoprolol Succinate per tablet

• Route of Administration: Oral

Status:

• Prescription Status: Prescription-only medication (Rx)

• Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for use in the treatment of hypertension and other cardiovascular conditions.

Benefits:

• Hypertension Management: Metoprolol Succinate is a beta-blocker that helps lower blood pressure by reducing the heart rate and the force of contraction, decreasing the workload on the heart.

• Angina Relief: It is effective in preventing chest pain (angina) by reducing the heart’s oxygen demand, especially during physical activity.

• Heart Failure Treatment: Metoprolol Succinate ER is often used in the management of chronic heart failure, improving survival and reducing hospitalization rates.

• Arrhythmia Management: It helps treat certain types of irregular heartbeats (arrhythmias), such as atrial fibrillation, by stabilizing the heart's rhythm.

• Post-Heart Attack Care: It is used to reduce the risk of mortality after a heart attack by protecting the heart from excessive strain.